KIES PETER has filed 43 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 25520 shares of INOVIO PHARMACEUTICALS, INC. ($INO) on March 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Restricted Stock Unit | 25520 | $0.00 | 25,520.0000 | 53,571,675 | 9999.99% | 0.05% |
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Common Stock Option | 31240 | $0.00 | 31,240.0000 | 53,571,675 | 9999.99% | 0.06% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 5010 | $0.00 | 5,009.0000 | 53,571,675 | 50.00% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 6294 | $1.79 | 37,017.0000 | 53,571,675 | 14.53% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 10634 | $0.00 | 43,311.0000 | 53,571,675 | 32.54% | 0.02% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 5010 | $0.00 | 35,642.0000 | 53,571,675 | 16.36% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2965 | $1.79 | 32,677.0000 | 53,571,675 | 8.32% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 10634 | $0.00 | 21,266.0000 | 53,571,675 | 33.34% | 0.02% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Common Stock Option | 31950 | $0.00 | 31,950.0000 | 36,667,221 | 9999.99% | 0.09% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Restricted Stock Unit | 26100 | $0.00 | 26,100.0000 | 36,667,221 | 9999.99% | 0.07% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 4771 | $0.00 | 4,771.0000 | 36,667,221 | 50.00% | 0.01% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 4771 | $0.00 | 33,198.0000 | 36,667,221 | 16.78% | 0.01% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2566 | $1.95 | 30,632.0000 | 36,667,221 | 7.73% | 0.01% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 5010 | $0.00 | 10,019.0000 | 0 | 33.34% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 3997 | $0.00 | 28,739.0000 | 0 | 16.15% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2362 | $1.98 | 26,377.0000 | 0 | 8.22% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 5010 | $0.00 | 31,387.0000 | 0 | 18.99% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2960 | $1.98 | 28,427.0000 | 0 | 9.43% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 3997 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Common Stock Option | 39050 | $0.00 | 39,050.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Restricted Stock Unit | 31900 | $0.00 | 31,900.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 4771 | $0.00 | 27,304.0000 | 0 | 21.17% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2562 | $13.07 | 24,742.0000 | 0 | 9.38% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 4771 | $0.00 | 9,542.0000 | 0 | 33.33% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 3997 | $0.00 | 3,997.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Common Stock Option | 18750 | $0.00 | 18,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Restricted Stock Unit | 15029 | $0.00 | 15,029.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 1878 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 2358 | $8.16 | 22,533.0000 | 0 | 9.47% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 3997 | $0.00 | 24,891.0000 | 0 | 19.13% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 1108 | $8.16 | 20,894.0000 | 0 | 5.04% | 0.00% |
| Feb. 26, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 1878 | $0.00 | 22,002.0000 | 0 | 9.33% | 0.00% |
| May 15, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Restricted Stock Unit | 171756 | $0.00 | 171,756.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 59737 | $0.00 | 272,909.0000 | 0 | 28.02% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 31410 | $1.13 | 241,499.0000 | 0 | 11.51% | 0.00% |
| March 11, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 59737 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 12928 | $1.28 | 193,400.0000 | 0 | 6.27% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 47967 | $0.00 | 241,367.0000 | 0 | 24.80% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 22544 | $0.00 | 22,544.0000 | 0 | 50.00% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | F | Common Stock | 28195 | $1.28 | 213,172.0000 | 0 | 11.68% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Restricted Stock Unit | 47967 | $0.00 | 95,933.0000 | 0 | 33.33% | 0.00% |
| Feb. 27, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | A | Common Stock Option | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | KIES PETER | CFO | M | Common Stock | 22544 | $0.00 | 206,328.0000 | 0 | 12.27% | 0.00% |